Trinean Secures 1 Million Euro Financing
News May 29, 2013
Trinean announced to have secured a 1 million euro investment in a second closing of its 3.7 million fundraising round. The investment is done by Capricorn Health-tech Fund NV (Leuven, Belgium) which is managed by Capricorn Venture Partners NV.
Dr. Gaston Matthyssens, Trinean’s president, comments on today’s announcement: “Over the past 24 months, Trinean has proven to be able to attract substantial funding to boost its market and sales strategy, and to bring novel, state-of-the-art instruments to the market. Most recently, we have launched the Xpose®, our new micro-volume spectrophotometer for high speed quantification of nucleic acid or proteins samples”.
Dr. Frank Bulens, Partner at Capricorn Venture Partners, will join Trinean’s board of directors. “We are very pleased to enforce the existing investor syndicate of Trinean and are looking forward to assist the company in reaching its next phase of development, namely to become a successful player in the micro-volume spectroscopy market,” comments Frank Bulens, “In our view Trinean will achieve that goal based on a superior product offering supported by a seasoned management team.”
“We are delighted to welcome Capricorn Health-tech Fund to our investor syndicate,” says Philippe Stas, CEO Trinean, “This will allow Trinean to accelerate its applicationdriven expansion of the DropSense96® and Xpose® product lines and to extend our production facilities, matching the increasing demand for instruments and microfluidic solutions.”
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management StrategyNews
Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.READ MORE
Automated Robotic Device Enables Faster Blood TestingNews
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.READ MORE